(Q34635798)

3 August 2017

1 reference

title

Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time (English)

1 reference

3 August 2017

Temporal lobe necrosis

1 reference

11

Lester J Peters

1 reference

3 August 2017

Anne W M Lee

1

1 reference

3 August 2017

Dora L W Kwong

2

1 reference

3 August 2017

Sing Fai Leung

3

1 reference

3 August 2017

Stewart Y Tung

4

1 reference

3 August 2017

Wai Man Sze

5

1 reference

3 August 2017

Jonathan S T Sham

6

1 reference

3 August 2017

Peter M L Teo

7

1 reference

3 August 2017

To Wai Leung

8

1 reference

3 August 2017

Po Man Wu

9

1 reference

3 August 2017

Rick Chappell

10

1 reference

3 August 2017

John F Fowler

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Radiation Oncology Biology Physics

3 August 2017

1 reference

3 August 2017

53

1 reference

3 August 2017

1

1 reference

3 August 2017

75-85

1 reference

Cerebral radiation necrosis following treatment of extracranial malignancies.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Cerebral necrosis following radiotherapy of extracranial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Dose fractionation, dose rate and iso-effect relationships for normal tissue responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Background mucosal changes in colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Magnetic resonance imaging in the clinical diagnosis of late temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Factors that modify the radio-response of cancer of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Radiation therapy for nasopharyngeal carcinoma. Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Carcinoma of the nasopharynx: a review of 86 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Radiation pneumonitis: A new approach to the derivation of time-dose factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Damage to mouse lung with neutrons and x-rays

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Effects of fractionated irradiation on mouse lung and a phenomenon of slow repair

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Time dependent repair of radiation damage in the rat spinal cord after X-rays and neutrons

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Turnover of proliferative cells in the spinal cord after X irradiation and its relation to time-dependent repair of radiation damage

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

The response of the pig lung to fractionated doses of X rays.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Radiation tolerance of the rat spinal cord: time-dose relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Dose, time, and fraction size issues for late effects in head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Radiotherapy with thrice-a-day fractionation in a short overall time: Clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Experience with CHART

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Impact of spinal cord repair kinetics on the practice of altered fractionation schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Kinetics of repair in the spinal cord of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

A new incomplete-repair model based on a 'reciprocal-time' pattern of sublethal damage repair.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Repair of radiation damage to capillary endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902711-6

7 January 2021

10.1016/S0360-3016(02)02711-6

Identifiers

DOI

1 reference

3 August 2017

1 reference